Prescribing: competence and scope of practice

In Prescribing support

Follow this topic

Bookmark

Record learning outcomes

Prescribing for the first time or returning to prescribing after a gap can be more daunting than it needs to be. The answer is not to wait until you feel ready for every patient or medicine, but to define a safe starting point: am I competent to make this decision, for this patient, in this setting, today?

Your independent prescriber annotation establishes your authority to prescribe, but it does not confer permanent competence across every condition or medicine.

Competence is contextual: you may be confident reviewing established hypertension yet unprepared to diagnose a new headache, prescribe during pregnancy or manage an unstable patient, even when the medicine itself is familiar.

This can be reassuring if you qualified months or years ago but haven’t prescribed much. You do not need to recreate the whole course before you begin. However, you do need to identify a useful area of practice, understand the capabilities it demands, and gather credible evidence that you can show these capabilities consistently.

Support and guidance

The General Pharmaceutical Council (GPhC) expects pharmacist prescribers to maintain and develop relevant knowledge and skills, while the Royal College of Pharmacy’s (RCPharm) Competency Framework for All Prescribers provides a practical map through consultation and prescribing governance.

A scope of practice should describe more than a condition or list of medicines. Saying you prescribe for hypertension, for example, does not explain who you will see, how unwell they may be, whether you will diagnose or only adjust treatment, or who should provide monitoring and follow-up.

These details determine the competence required and the risk involved. A practical test is to give the statement to a colleague: they should be able to predict which patients you will accept, which decisions you will make, and when you will stop and seek help.

Compare a pharmacist who titrates established antihypertensives for adults with confirmed primary hypertension, complete records and an agreed pathway, and a GP available for advice, with one who assesses walk-in patients with dizziness, raised blood pressure and incomplete histories.

The therapeutic area overlaps, but the work does not. A useful scope statement therefore describes the population, presentation, activities, medicines, setting, support and the findings that would prompt advice, referral or emergency action.

Start narrow

Begin your readiness check by reviewing several real cases, including one or two difficult ones. For each, consider what you need to know about the condition and treatment, what you need to learn from the patient, what examinations and tests you should perform, what decisions you need to make and communicate, and what follow-up is required.

Consider diagnostic uncertainty, red flags, multimorbidity, renal or hepatic impairment, pregnancy, frailty, interactions, allergy status and high-risk medicines. Then review the evidence of your current capability and how to build confidence. This may include supervised consultations, observed examinations, case discussions, prescribing data and feedback from patients or colleagues.

Course certificates and CPD support knowledge but do not on their own demonstrate performance – and feeling nervous does not mean you are incompetent. Confidence often comes later than capability, so the test should be what you can do safely and explain.

A supervisor who records that you recognised a contraindication and made an appropriate referral provides more assurance than a signature confirming attendance.

Mind the gap

It is also important to distinguish a knowledge gap from a work environment gap. If you understand the treatment but cannot access the full record, arrange investigations or guarantee review, more knowledge will not remove the risk.

Test the environment before your first consultation rather than discovering its limits with a patient in front of you: confirm you can see relevant correspondence, order and review investigations, document the decision and contact the patient promptly.

A safe beginning or return to prescribing usually begins with a deliberately narrow scope. Choose a patient group and activity with predictable presentations, strong guidance and established follow-up. Define exclusions and referral thresholds, and check that the service specification, local authorisation, indemnity and clinical system permissions support the work.

Organisational permission cannot make you clinically competent, and personal readiness does not authorise work outside an agreed service – both must be in place. Write exclusions in language that can be applied consistently.

Gather evidence

Refresh your knowledge against the cases you expect to see. Review the current guidelines, formulary and relevant BNF or BNFC content, together with MHRA safety advice and local monitoring or antimicrobial guidance.

Rehearse the consultation and learn the service’s documentation, incident, referral and safeguarding procedures. Targeted preparation linked to real cases is more useful than rereading an entire textbook.

Meaningful supervision is vital. Identify someone with relevant expertise who can be contacted during sessions and agree which cases will be observed, what must be discussed before prescribing and how urgent concerns will be escalated. Leading consultations under observation and receiving specific feedback provide stronger evidence of capability than shadowing alone.

Supervision should also have a planned end point, with agreed criteria for satisfactory performance, so progression is transparent rather than becoming a permanent substitute for competence.

Start with specifically defined cases, longer appointments and a manageable caseload, moving from observing to leading with direct supervision, then to prescribing with case review, and finally to agreed autonomy. Record that progression.

Review and record

Review a small sample early with a trusted colleague and ask whether the diagnosis, assessment, choice of treatment and safety-netting were all correct and complete.

Early review should look beyond whether the prescription was technically correct – ask whether the consultation gathered enough information and whether the follow-up actually happened. Checking the whole pathway can reveal risks invisible in the prescription record alone.

The RCPharm framework is most valuable as an active tool rather than a portfolio checklist. Strong pharmacology cannot compensate for a weak clinical assessment – and excellent consultation skills do not replace knowledge of contraindications or monitoring.

A technically correct prescription may still be unsafe if the diagnosis is wrong, the patient was not involved or nobody will review the result. Competence is the integration of these capabilities in the conditions in which you actually practise.

Keep a simple evidence record showing the capability considered, the evidence reviewed, feedback received, limits identified and action required. Choose evidence for quality rather than volume. Ten near-identical straightforward cases may show fluency but reveal little about recognising boundaries, while a smaller group of varied cases, including comorbidity, differing preferences and decisions not to prescribe, may tell you more.

Know when to say no

Knowing when not to prescribe is part of a safe scope of practice. You may need to refer because the history is incomplete, an examination is required, results are unavailable or the presentation lies outside your competence.

Explain what is missing, provide interim and safety-netting advice, and make a specific referral or follow-up plan. A decision not to prescribe should be documented with the same precision as a prescription: record the clinical concern, what was missing, the advice given and who takes responsibility next.

Be alert to pressures that can distort these boundaries, including patient expectation, waiting-time targets or a desire to prove yourself. If asked to work beyond your competence, state the patient safety concern and explain what would make the activity safe – training, supervision, equipment or a different referral pathway – and raise it through governance routes if it persists.

Patient pressure is easier to manage when boundaries are explained before disagreement arises.

Extend your scope safely

Extending scope should be treated as a clinical change, not simply the addition of another medicine. Moving from, say, stable hypertension to chronic kidney disease, from adults to children, from face-to-face to remote consultations, or from monitoring established treatment to diagnosing new disease can each require new capabilities, as can a high-risk medicine, unfamiliar formulation or diagnostic device.

Define the proposed extension precisely and compare it with your current work. Identify what transfers, what is new, what could go wrong and what controls are available. A small change may require targeted reading and several supervised cases; a substantial change may need formal education, assessed clinical skills and prolonged supervision.

Agree the extended scope with an appropriate supervisor and use review points rather than an arbitrary number of hours or cases – exposure is not the same as competence.

Repeated difficulty with the same interpretation or decision may indicate the extension is too broad; consistent performance across varied cases may justify a defined increase in autonomy.

Governance and teamwork

Before independent practice, make sure the right governance is in place. The service specification, pathways, formulary permissions, clinical system access, indemnity, audit arrangements and named escalation support should all cover the new work.

Introduce the extension in phases, review cases frequently and decide in advance what would prompt a pause, such as unexpected adverse events, repeated deviations or loss of supervision. Scope may sometimes need to contract after illness, a long gap or infrequent exposure.

Prescribing is team-based, but accountability for your decision remains yours. You may rely on a colleague’s examination, a laboratory result or a specialist plan, but you must judge whether the information is current, reliable and sufficient.

Clarify who will arrange tests, review results and respond to deterioration. Decision-support tools cannot replace clinical judgement when a patient does not fit the pathway, so shared responsibility depends on clear handovers.

Where roles are unclear, pause and resolve them before prescribing. Ambiguity afterwards can turn a sound decision into unsafe care.

A habit, not a finish line

The first goal should never be speed but a repeatable process: use a consultation structure, consult current sources, make your reasoning visible, safety-net clearly and arrange review. Debrief cases while the details are fresh. Over time, uncertainty should become more specific – not simply that you lack confidence, but that you need more practice interpreting a particular result or presentation.

Familiarity can create the opposite risk, allowing confidence to grow faster than competence. Continue to review unusual cases, adverse events and near misses, and compare your practice with peers and evidence-based standards.

You are ready to practise independently within a defined scope when you can manage common cases consistently, recognise and act on your limits, explain your reasoning and demonstrate this with credible evidence.

Competence is not a finish line. It is the habit of checking that your capability still matches the care you have undertaken to provide.

Jane Portlock is professor of pharmacy post-graduate education at the University of Reading